Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCPMasashi Iwamoto, Takaji Wakita, Koichi Watashi et al.|Biochemical and Biophysical Research Communications|2013Cited by 330
Cyclosporin A and Its Analogs Inhibit Hepatitis B Virus Entry Into Cultured Hepatocytes Through Targeting a Membrane Transporter, Sodium Taurocholate Cotransporting Polypeptide (NTCP)Koichi Watashi, Takaji Wakita, Ann E. Sluder et al.|Hepatology|2013Cited by 259
Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activitySatomi Shimura, Takaji Wakita, Kento Fukano et al.|Journal of Hepatology|2016Cited by 126
A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting PolypeptideManabu Kaneko, Takaji Wakita, Koichi Watashi et al.|Journal of Virology|2015Cited by 97
A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteinsSenko Tsukuda, Takaji Wakita, Koichi Watashi et al.|Hepatology|2016Cited by 80